• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Famotidine Against SARS-CoV2: A Hope or Hype?

作者信息

Ghosh Ritwik, Chatterjee Subhankar, Dubey Souvik, Lavie Carl J

机构信息

Department of General Medicine, Burdwan Medical College and Hospital, Burdwan, West Bengal, India.

Department of General Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India.

出版信息

Mayo Clin Proc. 2020 Aug;95(8):1797-1799. doi: 10.1016/j.mayocp.2020.05.027. Epub 2020 Jun 6.

DOI:10.1016/j.mayocp.2020.05.027
PMID:32753153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7275146/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057e/7275146/2e9eed412c69/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057e/7275146/2b0b7fb30d2a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057e/7275146/2e9eed412c69/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057e/7275146/2b0b7fb30d2a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/057e/7275146/2e9eed412c69/gr2_lrg.jpg

相似文献

1
Famotidine Against SARS-CoV2: A Hope or Hype?法莫替丁对新型冠状病毒2：希望还是炒作？
Mayo Clin Proc. 2020 Aug;95(8):1797-1799. doi: 10.1016/j.mayocp.2020.05.027. Epub 2020 Jun 6.
2
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study.法莫替丁的使用与住院COVID-19患者临床结局改善相关：一项倾向评分匹配的回顾性队列研究。
Gastroenterology. 2020 Sep;159(3):1129-1131.e3. doi: 10.1053/j.gastro.2020.05.053. Epub 2020 May 22.
3
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial.法莫替丁改善住院 COVID-19 患者结局的疗效：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 13;21(1):848. doi: 10.1186/s13063-020-04773-6.
4
Investigating hypothiocyanite against SARS-CoV-2.研究次硫氰酸盐对新型冠状病毒的作用。
Int J Hyg Environ Health. 2020 Jun;227:113520. doi: 10.1016/j.ijheh.2020.113520. Epub 2020 Apr 6.
5
Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis.A 类 G 蛋白偶联受体拮抗剂法莫替丁作为对抗 SARS-CoV-2 的治疗新选择：一项计算机模拟分析。
Biomolecules. 2020 Jun 24;10(6):954. doi: 10.3390/biom10060954.
6
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
7
Sofosbuvir for COVID-19 infection: A potential candidate.索磷布韦用于治疗新型冠状病毒肺炎感染：一个潜在的候选药物。
Indian J Pharmacol. 2020 May-Jun;52(3):232-233. doi: 10.4103/ijp.IJP_675_20. Epub 2020 Aug 4.
8
[Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].[严重急性呼吸综合征冠状病毒2（SARS-CoV-2）：我们应该针对病毒、细胞还是疾病？]
Virologie (Montrouge). 2020 Jun 1;24(3):135-141. doi: 10.1684/vir.2020.0843.
9
Favipiravir, an antiviral for COVID-19?法匹拉韦，一种用于治疗新冠肺炎的抗病毒药物？
J Antimicrob Chemother. 2020 Jul 1;75(7):2013-2014. doi: 10.1093/jac/dkaa171.
10
Evaluation of Potential Therapeutic Options for COVID-19.新型冠状病毒肺炎潜在治疗方案的评估
J Clin Pharmacol. 2020 Aug;60(8):976-977. doi: 10.1002/jcph.1669. Epub 2020 Jul 8.

引用本文的文献

1
The current landscape of the antimicrobial peptide melittin and its therapeutic potential.抗菌肽蜂毒肽的当前研究现状及其治疗潜力。
Front Immunol. 2024 Jan 22;15:1326033. doi: 10.3389/fimmu.2024.1326033. eCollection 2024.
2
Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection.蜂毒作为一种可能的抗SARS-CoV-2感染治疗方法的抗病毒特性。
Future Virol. 2023 Oct. doi: 10.2217/fvl-2023-0127. Epub 2023 Nov 7.
3
2-deoxy-D-glucose as India's Response to COVID-19: A Commitment or Conceit?

本文引用的文献

1
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
2
Immunomodulatory properties of cimetidine: Its therapeutic potentials for treatment of immune-related diseases.西咪替丁的免疫调节特性：其在治疗免疫相关疾病方面的治疗潜力。
Int Immunopharmacol. 2019 May;70:156-166. doi: 10.1016/j.intimp.2019.02.026. Epub 2019 Feb 22.
3
Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.
2-脱氧-D-葡萄糖作为印度应对新冠疫情的举措：是承诺还是自负？
J Community Hosp Intern Med Perspect. 2022 May 2;12(3):53-56. doi: 10.55729/2000-9666.1052. eCollection 2022.
4
Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells.组胺增强严重急性呼吸综合征冠状病毒2刺突蛋白进入内皮细胞的能力。
Front Pharmacol. 2022 Apr 25;13:872736. doi: 10.3389/fphar.2022.872736. eCollection 2022.
5
H antagonists, proton pump inhibitors and COVID-19.H拮抗剂、质子泵抑制剂与2019冠状病毒病
J Anesth. 2022 Jun;36(3):329-331. doi: 10.1007/s00540-021-03032-5. Epub 2022 Jan 24.
6
A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature.酸抑制药物、COVID-19及高度多样化文献的鸟瞰（再审视）
Front Pharmacol. 2021 Aug 11;12:700703. doi: 10.3389/fphar.2021.700703. eCollection 2021.
7
Impact of COVID-19 on a brain damage unit.COVID-19 对脑损伤病房的影响。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102163. doi: 10.1016/j.dsx.2021.05.036. Epub 2021 Jun 6.
8
In Reply-Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis.回复——法莫替丁的使用与新冠肺炎患者重症病程风险：一项荟萃分析。
Mayo Clin Proc. 2021 May;96(5):1367-1368. doi: 10.1016/j.mayocp.2021.03.002. Epub 2021 Mar 5.
9
Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19: A Meta-analysis.法莫替丁的使用与 COVID-19 患者重症病程风险：一项荟萃分析
Mayo Clin Proc. 2021 May;96(5):1365-1367. doi: 10.1016/j.mayocp.2021.03.001. Epub 2021 Mar 5.
10
Anaesthesia-related drugs and SARS-CoV-2 infection.麻醉相关药物与新型冠状病毒2型感染
Br J Anaesth. 2021 Jul;127(1):e32-e34. doi: 10.1016/j.bja.2021.03.026. Epub 2021 Apr 5.
炎症性肠病患者抑制对细菌配体的天然免疫反应需要组胺受体2 。
Inflamm Bowel Dis. 2016 Jul;22(7):1575-86. doi: 10.1097/MIB.0000000000000825.
4
Cimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell.西咪替丁与吡喹酮协同作用，通过激活细胞毒性CD8(+) T细胞增强乙肝病毒DNA疫苗的免疫反应。
Hum Vaccin Immunother. 2014;10(6):1688-99. doi: 10.4161/hv.28517. Epub 2014 Mar 18.
5
Histamine receptor 2 modifies dendritic cell responses to microbial ligands.组胺受体 2 调节树突状细胞对微生物配体的反应。
J Allergy Clin Immunol. 2013 Jul;132(1):194-204. doi: 10.1016/j.jaci.2013.01.013. Epub 2013 Mar 1.
6
Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients.在 HIV 感染患者中，H2 受体拮抗剂法莫替丁对含或不含替诺福韦的阿扎那韦-利托那韦的药代动力学的影响。
AIDS Patient Care STDS. 2011 Sep;25(9):509-15. doi: 10.1089/apc.2011.0113. Epub 2011 Jul 19.
7
Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.抑酸药物的使用与肺炎风险：系统评价和荟萃分析。
CMAJ. 2011 Feb 22;183(3):310-9. doi: 10.1503/cmaj.092129. Epub 2010 Dec 20.
8
Cytokine responses of intraepithelial lymphocytes are regulated by histamine H(2) receptor.上皮内淋巴细胞的细胞因子反应受组胺H(2)受体调控。
J Gastroenterol. 2009;44(4):285-96. doi: 10.1007/s00535-009-0019-9. Epub 2009 Mar 10.
9
Bismuth complexes inhibit the SARS coronavirus.铋配合物可抑制严重急性呼吸综合征冠状病毒。
Angew Chem Int Ed Engl. 2007;46(34):6464-8. doi: 10.1002/anie.200701021.
10
Histamine inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in an intercellular adhesion molecule-1- and B7.1-dependent manner.组胺以细胞间黏附分子-1和B7.1依赖性方式抑制脂多糖诱导的肿瘤坏死因子-α产生。
J Pharmacol Exp Ther. 2003 Feb;304(2):624-33. doi: 10.1124/jpet.102.042515.